Avelumab in patients with gestational trophoblastic tumors resistant to monochemotherapy: Final outcomes of TROPHIMMUN phase II trial, cohort A.

Benoit You,Pierre-Adrien Bolze,Jean-Pierre Lotz,Jérôme Massardier,Laurence Gladieff,Florence Joly,Touria Hajri,Delphine Maucort-Boulch,Sylvie Bin,Pascal Rousset,Laurent Villeneuve,Adeline Roux,Marine Alves-Ferreira,Daniele Grazziotin,Catherine Mercier,Gilles Freyer,François Golfier

Avelumab in patients with gestational trophoblastic tumors resistant to monochemotherapy: Final outcomes of TROPHIMMUN phase II trial, cohort A.

2020

Benoit You
Pierre-Adrien Bolze
Jean-Pierre Lotz
Jérôme Massardier
Laurence Gladieff
Florence Joly
Touria Hajri
Delphine Maucort-Boulch
Sylvie Bin
Pascal Rousset
Laurent Villeneuve
Adeline Roux
Marine Alves-Ferreira
Daniele Grazziotin
Catherine Mercier
Gilles Freyer
François Golfier

LBA6008Background: Patients with gestational trophoblastic tumors (GTT) resistant to monochemotherapy are treated with historic chemotherapy regimens known to be effective, but toxic. PD-L1 is cons...

Keywords:

Oncology
Cohort
Avelumab
Trophoblastic Tumor
Pathology
Gestation
in patient
Chemotherapy
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations